Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00737 cysteamine ophthalmic solution 0.37% (Cystadrops)PayerPolicy · BCBSLA-00737-3A79BF6A5C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00736 satralizumab-mwge (Enspryng), inebilizumab-cdon (Uplizna)PayerPolicy · BCBSLA-00736-82FC2948DB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00735 triheptanoin oral liquid (Dojolvi)PayerPolicy · BCBSLA-00735-56DCC72997 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00734 mannitol (Bronchitol)PayerPolicy · BCBSLA-00734-0E394E34EC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00733 Sphingosine-1-Phosphate (S1P) Receptor Modulators (Gilenya, Mayzent, Zeposia, Ponvory, Tascenso ODT, Velsipity)PayerPolicy · BCBSLA-00733-51F0582FB0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00732 Conjupri (levamlodipine)PayerPolicy · BCBSLA-00732-36327B0E0D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00731 Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Breast Cancer- Retired PolicyPayerPolicy · BCBSLA-00731-154F4B669E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00730 Novel Medications for the Treatment of Uterine FibroidsPayerPolicy · BCBSLA-00730-F7467F1683 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00729 Select Octreotide MedicationsPayerPolicy · BCBSLA-00729-6450C430B1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00728 Select Long-Acting Insulin ProductsPayerPolicy · BCBSLA-00728-CE9D120F22 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00727 ofatumumab (Kesimpta)PayerPolicy · BCBSLA-00727-DA6507B471 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00726 Select Erectile Dysfunction MedicationsPayerPolicy · BCBSLA-00726-97BDB29287 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00725 bimatoprost Implant (Durysta)PayerPolicy · BCBSLA-00725-7E98593222 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00724 Nasal Swell Body Ablation Reduction in the Treatment of Nasal ObstructionPayerPolicy · BCBSLA-00724-C944ABD56C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00723 Ablation and Surgical Treatment of Chronic RhinitisPayerPolicy · BCBSLA-00723-A8EC4F6B36 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00722 Pharmacotherapy for Neurofibromatosis Type 1PayerPolicy · BCBSLA-00722-C58C7E73D2 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00721 osilodrostat (Isturisa)PayerPolicy · BCBSLA-00721-5846B5DD93 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00720 Select Fenofibrate ProductsPayerPolicy · BCBSLA-00720-4EB7DAA4B4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00719 Fumaric Acids for the Treatment of Multiple SclerosisPayerPolicy · BCBSLA-00719-1804022224 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00718 afamelanotide (Scenesse)PayerPolicy · BCBSLA-00718-D792D867EC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00717 Select Topical Antibiotics/CombinationsPayerPolicy · BCBSLA-00717-196B6DFD49 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00716 Cromolyn Nebulized SolutionPayerPolicy · BCBSLA-00716-0B86840DF2 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00715 Select Nitrofurantoin ProductsPayerPolicy · BCBSLA-00715-8DA6F1EF61 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00714 bempedoic acid Products (Nexletol, Nexlizet)PayerPolicy · BCBSLA-00714-65FFC10374 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00713 Zerviate (cetirizine ophthalmic solution)PayerPolicy · BCBSLA-00713-7170A1E294 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00712 infliximab-axxq (Avsola)- Retired PolicyPayerPolicy · BCBSLA-00712-70F56030FD | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00711 Functional Endoscopic Sinus Surgery for Chronic RhinosinusitisPayerPolicy · BCBSLA-00711-887D3762C0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00710 Lipid ApheresisPayerPolicy · BCBSLA-00710-DB03E8F5B3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00709 peanut (Arachis hypogaea) allergen powder-dnfp (Palforzia)PayerPolicy · BCBSLA-00709-A24BDA1305 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00708 teprotumumab-trbw (Tepezza)PayerPolicy · BCBSLA-00708-9AFC76E498 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00707 Select Antipsychotic DrugsPayerPolicy · BCBSLA-00707-8D6032B635 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00706 Germline Genetic Testing for Pancreatic Cancer Susceptibility Genes- Retired PolicyPayerPolicy · BCBSLA-00706-794A95D574 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00705 givosiran (Givlaari)PayerPolicy · BCBSLA-00705-08503EE78F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00704 Novel Treatments for Sickle Cell Disease (Adakveo)PayerPolicy · BCBSLA-00704-4FB1FB841C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00703 luspatercept-aamt (Reblozyl)PayerPolicy · BCBSLA-00703-BD451A00EB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00702 Immune Cell Function Assay - Retired PolicyPayerPolicy · BCBSLA-00702-E52FCE327C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00701 Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia and GastroparesisPayerPolicy · BCBSLA-00701-C46C94A6B1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00700 pitolisant (Wakix)PayerPolicy · BCBSLA-00700-80A5E5A94E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00699 Light Therapy for Vitiligo- Retired PolicyPayerPolicy · BCBSLA-00699-92254FAB80 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00698 Select Novel Drug FormulationsPayerPolicy · BCBSLA-00698-A138A79D55 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00697 elexacaftor/tezacaftor/ivacaftor (Trikafta)PayerPolicy · BCBSLA-00697-86544E5C94 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00696 Pharmacotherapy for Tenosynovial Giant Cell TumorPayerPolicy · BCBSLA-00696-EA9DAEEF0C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00695 Sunosi (solriamfetol)PayerPolicy · BCBSLA-00695-1EECD2E026 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00694 tafamidis (Vyndamax)PayerPolicy · BCBSLA-00694-150DC32CA1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00693 Select Levothyroxine ProductsPayerPolicy · BCBSLA-00693-3C03EC8257 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00692 upadacitinib (Rinvoq, Rinvoq LQ)PayerPolicy · BCBSLA-00692-81DF25BD02 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00691 Vein Embolization as a Treatment for Pelvic Congestion Syndrome and VaricocelePayerPolicy · BCBSLA-00691-C53A145412 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00690 Invasive Prenatal (Fetal) Diagnostic Testing- Retired PolicyPayerPolicy · BCBSLA-00690-AD6E880077 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00689 cladribine (Mavenclad)PayerPolicy · BCBSLA-00689-712695F117 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00688 Leadless Cardiac Pacemakers-Retired PolicyPayerPolicy · BCBSLA-00688-490F5786A3 | New policy |
|---|